QR код

Iatrogenic botulism after intragastric botulinum neurotoxin injections – a major outbreak

Abstract Background Intragastric botulinum neurotoxin injections (IBNI) are offered off-label in the private medical sector in a few European countries as a safe and effective weight-loss measure. In February and March 2023, an outbreak of iatrogenic botulism occurred in several European countries f...

Повний опис

Збережено в:
Автори: Tsepo Goerttler, Martin B. Dorner, Christina van der Linden, Ricardo Kienitz, Stephan Petrik, Stephan Blechinger, Jonah Spickschen, Iris R. Betz, Carl Hinrichs, David Steindl, Frederike Weber, Thomas Musacchio, Gilbert Wunderlich, Maria Adele Rueger, Michael T. Barbe, Haidar Dafsari, Seda Demir, Sriramya Lapa, Pia S. Zeiner, Adam Strzelczyk, Peter Tinnemann, Christian Kleine, Andreas Totzeck, Stephan Klebe, Agata Mikolajewska, Brigitte G. Dorner, Elisabeth Fertl, Christian Grefkes-Hermann, Gereon Fink, Christoph Kleinschnitz, Tim Hagenacker
Формат: Artigo
Мова:Inglês
Опубліковано: BMC 2024-10-01
Серія:Neurological Research and Practice
Предмети:
Iatrogenic botulism
Intensive care
Botulinum neurotoxin
Off-label use
Онлайн доступ:https://doi.org/10.1186/s42466-024-00350-3
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси